We have previously shown that sigma-2 receptors are upregulated in pancreatic cancer, that sigma-2 ligands can induce caspase-3-mediated apoptisis, and are effective in preclinical models of pancreatic cancer [8-10]. The gene discussed is CASP3; the disease is familial pancreatic carcinoma.